Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Agios Pharmaceuticals News

    31,53 $ -0,44% -0,14 $
    In : 29,430 € | 16:44:49 Uhr Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1W2RM
    ISIN: US00847X1046
    US-Symbol: AGIO
    Typ: Aktie

    Agios Pharmaceuticals News

    03.01.24 - PR Newswire
    Thinking about trading options or stock in Agios Pharmaceuticals, Moderna, Vertex Pharmaceuticals, Applied Materials, or Hut 8?
    Thinking about trading options or stock in Agios Pharmaceuticals, Moderna, Vertex Pharmaceuticals, Applied Materials, or Hut 8? PR Newswire
    12.04.23 - PR Newswire
    Totus Medicines Expands its Scientific Advisory Board with the Addition of Dr. Lewis Cantley, Dr. Hope Rugo, and Dr. Josep Tabernero
    Totus Medicines Expands its Scientific Advisory Board with the Addition of Dr. Lewis Cantley, Dr. Hope Rugo, and Dr. Josep Tabernero PR Newswire
    20.12.21 - Wikifolio
    Die Top-Aktien der letzten Woche
    Ob Gewinn­mit­nahmen, Nachkäufe bei fallenden Kursen oder der Klassiker: Die Angst, etwas zu verpassen... hier erfahren Sie, welche Aktien die wikifolio-​Trader kaufen und ...
    24.10.18 - Der Aktionär
    BB Biotech: Diese Biotech-Werte überzeugten im dritten Quartal, diese enttäuschten
    12.02.18 - Der Aktionär
    Celgene im Übernahmefieber: Darum passt die BB-Biotech-Beteiligung Agios ins Beuteschema
    02.08.17 - Der Aktionär
    BB Biotech Beteiligungs-Duo Celgene und Agios mit starken News
    16.12.16 - PR Newswire
    INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Agios Pharmaceuticals, Inc. and Certain Officers and Directors -- AGIO
    INVESTOR ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Agios Pharmaceuticals, Inc. and Certain Officers and ...
    15.12.16 - PR Newswire
    Flagship Ventures Evolves Name To Flagship Pioneering
    Flagship Ventures Evolves Name To Flagship Pioneering Announces Innovative $285 Million Follow-on Capital Pool for Special Opportunities PR Newswire
    06.12.16 - PR Newswire
    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Agios Pharmaceuticals, Inc. (AGIO)
    SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Agios Pharmaceuticals, Inc. (AGIO) PR Newswire
    15.11.16 - PR Newswire
    Learn how to target a 20% return on Sears Holdings, or get option-trade ideas on Intrexon, Agios Pharmaceuticals, Mattel Inc. and Myriad Genetics or any stock you choose
    Learn how to target a 20% return on Sears Holdings, or get option-​trade ideas on Intrexon, Agios Pharmaceuticals, Mattel Inc. and Myriad Genetics or any stock you choose PR ...
    08.09.16 - PR Newswire
    InvestorsObserver releases covered-call reports for Valeant Pharmaceuticals, Agios Pharmaceuticals, Apache Corporation, FireEye and Coca-Cola Enterprises
    InvestorsObserver releases covered-​call reports for Valeant Pharmaceuticals, Agios Pharmaceuticals, Apache Corporation, FireEye and Coca-Cola Enterprises PR Newswire
    13.07.16 - PR Newswire
    Dr. Michael Rosenblatt Joins Flagship Ventures as Chief Medical Officer
    Dr. Michael Rosenblatt Joins Flagship Ventures as Chief Medical Officer New Position Created to Support Growing Clinical Research Programs Across Flagship's Start-up ...
    29.06.16 - PR Newswire
    Flagship Ventures Names Daniel McIntyre Partner
    Flagship Ventures Names Daniel McIntyre Partner Industry Veteran Assumes new position to lead strategic communication PR Newswire
    28.10.15 - PR Newswire
    Covered Call Alerts For Corning Inc., Seadrill, Arrowhead Research, Intrexon and Agios Pharmaceuticals Released By InvestorsObserver
    Covered Call Alerts For Corning Inc., Seadrill, Arrowhead Research, Intrexon and Agios Pharmaceuticals Released By InvestorsObserver PR Newswire
    28.08.13 - PR Newswire
    The World Economic Forum Recognizes Four Flagship Ventures Portfolio Companies as Technology Pioneers for 2014
    The World Economic Forum Recognizes Four Flagship Ventures Portfolio Companies as Technology Pioneers for 2014 Agios Pharmaceuticals, BIND Therapeutics, Oasys Water ...

    Newssuche

    Videos

    newspaper
    09:30 Uhr +53,66%
    Technical Trading: S&P 500 Short Chance
    S&P 500 Short Typ: Turbo Open End WKN: NG8FUZ Hebel: 31 Laufzeit: OpenEnd Einstieg: Market ... Mehr »